The therapeutic potential of green tea as a rich source of antioxidants and anti‐inflammatory
compounds has been investigated by several studies. The present study aimed to …

This study aimed to evaluate the efficacy of green tea supplementation on nonalcoholic fatty
liver disease treatment. Electronic databases, including PubMed, Scopus, Web of Science …

Epigallocatechin-3-gallate (EGCG) is a polyphenol green tea catechin with potential health
benefits and therapeutic effects in non-alcoholic fatty liver disease (NAFLD), a common liver …

Aim: There have been many reports on the reduction of liver disease with green tea
consumption. This study aims to evaluate the body of evidence related to green tea …

Objectives: To present the effect of green tea consumption against liver disease. Data
sources: Interventional and observational studies both in Western countries and in China …

There remain liver-related safety concerns, regarding potential hepatotoxicity in humans,
induced by green tea intake, despite being supposedly beneficial. Although many …

Catechins, a major component of green tea extract, have anti-hyperlipidemic effects. The
present study investigated the effects of consumption of green tea with high-density …

Nonalcoholic fatty liver disease (NAFLD) is a typical chronic liver disease highly correlated
with metabolic syndrome. Growing prevalence of NAFLD is supposed to be linked with the …

Nonalcoholic fatty liver diseases (NAFLD) represent a set of liver disorders progressing from
steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, which induce …

Background Several studies reported that curcumin supplementation could improve non-
alcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the efficacy of …